Investigations

The law firm of Kirby McInerney LLP is investigating potential claims against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL; GOOG) securities between May 19, 2026 and July 16, 2026, inclusive (“the Class Period”). If you suffered a loss on your Alphabet investments, you have until December 1, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Amdocs securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (“the Class Period”). If you suffered a loss on your Anavex investments, you have until November 30, 2026 to request lead plaintiff appointment.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) securities between February 12, 2026 and August 5, 2026, inclusive (“the Class Period”). If you suffered a loss on your AppLovin investments, you have until November 16, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Arbor Realty Trust, Inc. (“Arbor Realty” or the “Company”) (NYSE: ABR) securities between February 27, 2026 and October 30, 2026, inclusive (“the Class Period”). If you suffered a loss on your Arbor Realty investments, you have until January 18, 2026 to request lead plaintiff appointment. 

he law firm of Kirby McInerney LLP is investigating potential claims against Arrivent BioPharma (“Arrivent” or the “Company”) (NASDAQ: AVBP). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Arrivent securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Axon Enterprise, Inc. (“Axon” or the “Company”) (NASDAQ: AXON). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Axon securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces an investigation on behalf of Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Better Home & Finance Holding Company (“Better Home” or the “Company”) (NASDAQ: BETR) securities between March 13, 2026 and May 7, 2026, inclusive (“the Class Period”). If you suffered a loss on your Better Home investments, you have until November 20, 2026 to request lead plaintiff appointment.
 

The law firm of Kirby McInerney LLP is investigating potential claims against Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Biodesix securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Bright Minds Biosciences (“Bright Minds” or the “Company”) (NASDAQ: DRUG). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Bright Minds securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Coastal Financial Corporation (“Coastal” or the “Company”) (NSADAQ: CCB) securities between October 28, 2024 and July 29, 2026, inclusive (“the Class Period”). If you suffered a loss on your Coastal investments, you have until December 1, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of former Anywhere Real Estate Inc. (“Anywhere”) (formerly trading as NYSE: HOUS) investors who acquired Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP) common stock in direct exchange for Anywhere securities pursuant to the S-4 registration statement, 424B3 prospectus, and related oral communications (collectively, with materials incorporated therein, the “Registration Statement” or “Offering Materials”), issued in connection with the January 2026 stock-for-stock exchange by which Compass acquired and merged with Anywhere (the “Merger”). If you suffered a loss on your Compass investments, you have until December 7, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against Credit Acceptance Corporation (“Credit Acceptance” or the “Company”) (NASDAQ: CACC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Credit Acceptance securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Criteo S.A. (“Criteo” or the “Company”) (NASDAQ: CRTO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. 
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) securities between July 25, 2023 and August 6, 2026, inclusive (“the Class Period”). If you suffered a loss on your CVRx investments, you have until January 8, 2027 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against Dave, Inc. (“Dave” or the “Company”) (NASDAQ: DAVE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Dave securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Dick’s Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Dick’s securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP is investigating potential claims against Digital Turbine, Inc. (“Digital Turbine” or the “Company”) (NASDAQ: APPS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Digital Turbine securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) securities between May 2, 2025 and February 26, 2026, inclusive (“the Class Period”). If you suffered a loss on your Duolingo investments, you have until December 7, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Endava plc (“Endava” or the “Company”) (NYSE: DAVA) securities between September 4, 2025 and September 21, 2026, inclusive (“the Class Period”). If you suffered a loss on your Endava investments, you have until November 30, 2026 to request lead plaintiff appointment.

The law firm of Kirby McInerney LLP is investigating potential claims against Enova International, Inc. (“Enova” or the “Company”) (NYSE: ENVA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Enova securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP is investigating potential claims against EyePoint Pharmaceuticals (“EyePoint” or the “Company”) (NASDAQ:  EYPT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. 
 

The law firm of Kirby McInerney LLP is investigating potential claims against Fervo Energy Company (“Fervo” or the “Company”) (NASDAQ: FRVO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Fervo securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (NASDAQ: FCFS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired FirstCash securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Fluence Energy, Inc. (“Fluence Energy” or the “Company”) (NASDAQ: FLNC) securities between November 24, 2025 and September 16, 2026, inclusive (“the Class Period”). If you suffered a loss on your Fluence Energy investments, you have until November 27, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against FreightCar America, Inc. (“FreightCar” or the “Company”) (NASDAQ: RAIL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired FreightCar securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Gilat Satellite Networks Ltd. (“Gilat” or the “Company”) (NADAQ: GILT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Gilat securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Goosehead securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Honeywell Aerospace Inc. (“Honeywell Aerospace” or the “Company”) (NASDAQ: HONA) securities between June 29, 2026 and September 1, 2026, inclusive (“the Class Period”). If you suffered a loss on your Honeywell Aerospace investments, you have until November 23, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Integra securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Kinross Gold Corporation (“Kinross” or the “Company”) (NYSE: KGC) securities between February 18, 2026 and September 23, 2026, inclusive (“the Class Period”). If you suffered a loss on your Kinross investments, you have until January 5, 2027 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against Lennar Corporation (“Lennar” or the “Company”) (NYSE: LEN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Lennar securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Liquidia securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Madrigal Pharmaceuticals, Inc. (“Madrigal” or the “Company”) (NASDAQ: MDGL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Madrigal securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Medline securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP) securities between February 7, 2025 and October 2, 2026, inclusive (“the Class Period”). If you suffered a loss on your Millrose investments, you have until December 8, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against MNTN, Inc. (“MNTN” or the “Company”) (NYSE: MNTN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired MNTN securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Montauk Renewables, Inc. (“Montauk” or the “Company”) (NASDAQ: MNTK). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired Montauk securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP is investigating potential claims against Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Netcapital Inc. (“Netcapital” or the “Company”) (NASDAQ: NCPL) securities between December 15, 2021 and September 3, 2026, inclusive (“the Class Period”). If you suffered a loss on your Netcapital investments, you have until December 7, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against NVE Corporation (“NVE” or the “Company”) (NASDAQ: NVE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.  If you purchased or otherwise acquired NVE securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired OI-Glass, Inc. (“OI-Glass” or the “Company”) (NYSE: OI) securities between March 14, 2025 and July 28, 2026, inclusive (“the Class Period”). If you suffered a loss on your OI-Glass investments, you have until December 28, 2026 to request lead plaintiff appointment. 

The law firm of Kirby McInerney LLP is investigating potential claims against OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired OSI securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.